Timothy Tyson

Chief Executive Officer, VALEANT PHARMACEUTICALS INTERNATIONAL.

Companies

Syros Pharmaceuticals, Inc.Board member Sep 19, 2022 to Jun 7, 2024¹
TYME TECHNOLOGIES, INC.Board member Jul 27, 2017 to Sep 16, 2022²
BIODELIVERY SCIENCES INTERNATIONAL INCBoard member Oct 6, 2016 to Aug 16, 2017³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

TYME TECHNOLOGIES, INC.0 shares⁴Sep 16, 2022
Syros Pharmaceuticals, Inc.33,189 shares⁵Jun 5, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 5, 2024Granted 4,000 shares of Syros Pharmaceuticals, Inc.⁵
Jun 1, 2023Granted 4,000 shares of Syros Pharmaceuticals, Inc.⁶
Sep 30, 2022Bought 14,000 shares at $6.37 of Syros Pharmaceuticals, Inc.⁷
Sep 29, 2022Bought 2,932 shares at $5.72 of Syros Pharmaceuticals, Inc.⁷
Sep 16, 2022Granted 257 shares of Syros Pharmaceuticals, Inc.⁸
Sep 16, 2022Returned to company 5,865 shares of TYME TECHNOLOGIES, INC.⁴
Sep 16, 2022Granted 8,000 shares of Syros Pharmaceuticals, Inc.⁹
Sep 16, 2022Granted 8,000 shares of Syros Pharmaceuticals, Inc.⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSyros Pharmaceuticals, Inc., Board member
2
SEC EDGARTYME TECHNOLOGIES, INC., Board member
3
SEC EDGARBIODELIVERY SCIENCES INTERNATIONAL INC, Board member
4
SEC EDGARTYME TECHNOLOGIES, INC. shares after the filing of Sep 16, 2022
5
SEC EDGARSyros Pharmaceuticals, Inc. shares after the filing of Jun 5, 2024
6
SEC EDGARForm 4 filed Jun 2, 2023
7
SEC EDGARForm 4 filed Oct 3, 2022
8
SEC EDGARForm 4 filed Apr 20, 2023
9
SEC EDGARForm 4 filed Sep 19, 2022